Chakrabarty, Satya
Chakrabarty, Satya was paid $1.82M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoCHAKRABARTY, SATYA
COOKEVILLE, TN 38501
COOKEVILLE, TN 38501
33aNPI1982719092assigned 08/20/2006
33bProvider typeSpecialist
28Total paid$1.82M
24GClaims86,603
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#18 of 252
Median peer was paid$57K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,139 | $325K | |
| 2019 | 26,206 | $595K | |
| 2020 | 17,422 | $375K | |
| 2021 | 21,419 | $444K | |
| 2022 | 2,678 | $49K | |
| 2023 | 1,709 | $22K | |
| 2024incomplete | 1,030 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 10,226 | 7,249 | $493K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 4,393 | 3,217 | $315K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.0% | 5,350 | 3,815 | $163K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.3% | 2,010 | 1,466 | $132K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.5% | 1,512 | 1,197 | $100K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.9% | 1,208 | 818 | $88K |
| D1206 | Topical application of fluoride varnish | 4.3% | 4,859 | 4,790 | $79K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.2% | 2,694 | 2,025 | $77K |
| D0190 | 2.7% | 4,915 | 4,854 | $48K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 4,583 | 1,893 | $46K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 4,148 | 2,981 | $39K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 659 | 572 | $38K |
49 more codes
| 92551 | 1.9% | 4,466 | $35K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 4,254 | $27K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 3,384 | $20K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 524 | $18K |
| 96127 | <1% | 3,719 | $17K | |
| 96160 | <1% | 2,988 | $13K | |
| 99401 | <1% | 512 | $13K | |
| 99177 | <1% | 4,438 | $11K | |
| 81002 | <1% | 4,743 | $10K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 546 | $10K |
| 87807 | <1% | 976 | $9K | |
| 3008F | <1% | 591 | $5K | |
| 85018 | <1% | 1,546 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 77 | $1K |
| 0071A | <1% | 53 | $1K | |
| 83655 | <1% | 122 | $1K | |
| 0072A | <1% | 22 | $649.96 | |
| 99423 | <1% | 21 | $557.55 | |
| 96161 | <1% | 268 | $387.38 | |
| 99422 | <1% | 21 | $352.38 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 34 | $175.80 |
| 81025 | <1% | 36 | $175.68 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 422 | $135.69 |
| 99173 | <1% | 118 | $115.80 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 63 | $113.10 |
| 90686 | <1% | 1,400 | $87.04 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 23 | $30.69 |
| 90674 | <1% | 54 | $22.70 | |
| 36416 | <1% | 1,255 | $3.66 | |
| 90670 | 0% | 625 | $0.00 | |
| 90648 | 0% | 182 | $0.00 | |
| 90633 | 0% | 217 | $0.00 | |
| 90658 | 0% | 294 | $0.00 | |
| 90734 | 0% | 160 | $0.00 | |
| 90672 | 0% | 233 | $0.00 | |
| 90715 | 0% | 17 | $0.00 | |
| 90681 | 0% | 12 | $0.00 | |
| 90461 | 0% | 47 | $0.00 | |
| 90707 | 0% | 33 | $0.00 | |
| 90651 | 0% | 569 | $0.00 | |
| 90698 | 0% | 232 | $0.00 | |
| 90688 | 0% | 377 | $0.00 | |
| 90723 | 0% | 151 | $0.00 | |
| 90744 | 0% | 17 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 61 | $0.00 |
| 90716 | 0% | 29 | $0.00 | |
| 91307 | 0% | 76 | $0.00 | |
| 90657 | 0% | 18 | $0.00 | |
| 90620 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.